Video Library - Pricing
F. Randy Vogenberg, PhD, RPh
Principal
Institute for Integrated Healthcare
Lead Collaborator
National Institute of Collaborative Healthcare
Greenville, SC
Randy Vogenberg discusses the complexities of developing pricing for personalized medicine products
Related Items
Economic Impact of Increased Utilization of Multivariate Assay Testing to Guide the Treatment of Ovarian Cancer: Implications for Payers
Burton S. Brodsky, MD, Gary M. Owens, MD, Dennis J. Scotti, PhD, MBA, Keith A. Needham, BS, Christina L. Cool, MPH
October 2017 Vol 10, No 7 published on November 9, 2017 in Business, Original Research
Sociodemographic Determinants of Out-of-Pocket Expenditures for Patients Using Prescription Drugs for Rheumatoid Arthritis
Kumar Mukherjee, PhD, Khalid M. Kamal, PhD
February 2017 Vol 10, No 1 published on February 17, 2017 in Business
Top 10 Healthcare Market Trends in 2017
John Santilli, MBA, F. Randy Vogenberg, PhD, RPh
February 2017 Vol 10, No 1 published on February 17, 2017 in Industry Trends
Employer Perspectives on a Specialty Drug Step-Therapy Program Evaluation
Matthew Harman, PharmD, MPH, F. Randy Vogenberg, PhD, RPh
September 2016 Vol 9, No 6 published on September 15, 2016 in Industry Trends
Hospital and Health Plan Partnerships: The Affordable Care Act’s Impact on Promoting Health and Wellness
Michelle Vu, PharmD candidate, Annesha White, PharmD, PhD, Virginia P. Kelley, MBA, Jennifer Kuca Hopper, MS, Cathy Liu, PharmD candidate
July 2016 Vol 9, No 5 published on July 18, 2016 in Business
Last modified: March 24, 2015
  •  Association for Value-Based Cancer Care
  • Value-Based Cancer Care
  • Value-Based Care in Rheumatology
  • Oncology Practice Management
  • Rheumatology Practice Management
  • Urology Practice Management
  • Inside Patient Care: Pharmacy & Clinic
  • Lynx CME